Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2005 1
2006 1
2010 4
2011 2
2012 3
2013 5
2014 5
2015 7
2016 5
2017 3
2018 5
2019 2
2020 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial.
Gentilini OD, Botteri E, Sangalli C, Galimberti V, Porpiglia M, Agresti R, Luini A, Viale G, Cassano E, Peradze N, Toesca A, Massari G, Sacchini V, Munzone E, Leonardi MC, Cattadori F, Di Micco R, Esposito E, Sgarella A, Cattaneo S, Busani M, Dessena M, Bianchi A, Cretella E, Ripoll Orts F, Mueller M, Tinterri C, Chahuan Manzur BJ, Benedetto C, Veronesi P; SOUND Trial Group. Gentilini OD, et al. Among authors: agresti r. JAMA Oncol. 2023 Nov 1;9(11):1557-1564. doi: 10.1001/jamaoncol.2023.3759. JAMA Oncol. 2023. PMID: 37733364 Free PMC article.
Adipocytes in Breast Cancer, the Thick and the Thin.
Rybinska I, Agresti R, Trapani A, Tagliabue E, Triulzi T. Rybinska I, et al. Among authors: agresti r. Cells. 2020 Feb 27;9(3):560. doi: 10.3390/cells9030560. Cells. 2020. PMID: 32120856 Free PMC article. Review.
SAA1-dependent reprogramming of adipocytes by tumor cells is associated with triple negative breast cancer aggressiveness.
Rybinska I, Mangano N, Romero-Cordoba SL, Regondi V, Ciravolo V, De Cecco L, Maffioli E, Paolini B, Bianchi F, Sfondrini L, Tedeschi G, Agresti R, Tagliabue E, Triulzi T. Rybinska I, et al. Among authors: agresti r. Int J Cancer. 2024 May 15;154(10):1842-1856. doi: 10.1002/ijc.34859. Epub 2024 Jan 30. Int J Cancer. 2024. PMID: 38289016 Free article.
FDG-PET for axillary lymph node staging in primary breast cancer.
Crippa F, Gerali A, Alessi A, Agresti R, Bombardieri E. Crippa F, et al. Among authors: agresti r. Eur J Nucl Med Mol Imaging. 2004 Jun;31 Suppl 1:S97-102. doi: 10.1007/s00259-004-1531-z. Epub 2004 May 5. Eur J Nucl Med Mol Imaging. 2004. PMID: 15133635 Review.
The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.
Forte L, Turdo F, Ghirelli C, Aiello P, Casalini P, Iorio MV, D'Ippolito E, Gasparini P, Agresti R, Belmonte B, Sozzi G, Sfondrini L, Tagliabue E, Campiglio M, Bianchi F. Forte L, et al. Among authors: agresti r. BMC Cancer. 2018 May 23;18(1):586. doi: 10.1186/s12885-018-4500-9. BMC Cancer. 2018. PMID: 29792166 Free PMC article.
Neoadjuvant Chemotherapy Exerts Selection Pressure Towards Luminal Phenotype Breast Cancer.
Galli G, Bregni G, Cavalieri S, Porcu L, Baili P, Hade A, Di Salvo F, Sant M, Agresti R, Gennaro M, Folli S, De Santis MC, Paolini B, Carcangiu ML, de Braud F, Di Cosimo S. Galli G, et al. Among authors: agresti r. Breast Care (Basel). 2017 Dec;12(6):391-394. doi: 10.1159/000479582. Epub 2017 Dec 12. Breast Care (Basel). 2017. PMID: 29456471 Free PMC article.
CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.
Turdo F, Bianchi F, Gasparini P, Sandri M, Sasso M, De Cecco L, Forte L, Casalini P, Aiello P, Sfondrini L, Agresti R, Carcangiu ML, Plantamura I, Sozzi G, Tagliabue E, Campiglio M. Turdo F, et al. Among authors: agresti r. Oncotarget. 2016 Oct 25;7(43):69649-69665. doi: 10.18632/oncotarget.11935. Oncotarget. 2016. PMID: 27626701 Free PMC article.
47 results